Mag. sc. hum. Mag. pharm. Dr. scient. med. Sabine Geiger-Gritsch

Sabine Geiger-Gritsch has been Deputy Director and Lead of the Research Area Drug Assessment at AIHTA since 2025. She previously worked at the former Ludwig Boltzmann Institute for Health Technology Assessment (LBI-HTA), now AIHTA, from 2007 to 2010 and again from 2018 to 2019. Her research focuses on evidence-based pharmaceutical assessment, particularly the evaluation of innovative therapies in oncology and rare diseases, as well as the further development of HTA methodologies and the conduct of assessments under the EU HTA Regulation.

She holds a degree in Pharmacy from the University of Innsbruck, a PhD in Medical Sciences from the Medical University of Innsbruck, and a degree in Health Sciences from UMIT TIROL.

Before assuming her current position, she worked as a hospital pharmacist at Innsbruck University Hospital, specializing in clinical pharmacy. She also served as a researcher and project manager at UMIT TIROL and LBI-HTA/AIHTA and gained extensive experience in translating scientific evidence into healthcare decision-making through her positions at Tirol Kliniken and Wiener Gesundheitsverbund.

Memberships:

• Advisory Board on Oncology, Austrian Federal Ministry of Labour, Social Affairs, Health, Care and Consumer Protection
• Advisory Board on Cancer Statistics/Cancer Registry, Statistics Austria
• Austrian Public Health Association (ÖGPH)
• Austrian Society of Epidemiology (OeGEp)
• German Network for Health Services Research (DNVF)
• German Association for Medical Informatics, Biometry and Epidemiology (GMDS)
• German Network for Evidence-Based Medicine (EBM Network)